Design, synthesis and anticancer activity of naphthoquinone derivatives

References

• Zhao TT, Xu H, Xu HM, et al. The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials. Gastric Cancer 2018;21:361–71.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008;132:27–42.
   PubMed Web of Science ®Google Scholar
• Cao Y, Luo Y, Zou J, et al. Autophagy and its role in gastric cancer. Clin Chim Acta 2019;489:10–20.
   PubMed Web of Science ®Google Scholar
• Satyavarapu EM, Das R, Mandal C, et al. Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells . Cell Death Dis 2018;9:934.
   PubMed Web of Science ®Google Scholar
• Eisenberg-Lerner A, Bialik S, H-U S, et al. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009;16:966.
   PubMed Web of Science ®Google Scholar
• Meng Y, Yong Y, Yang G, et al. Autophagy alleviates neurodegeneration caused by mild impairment of oxidative metabolism. J Neurochem 2013;126:805–18.
   PubMed Web of Science ®Google Scholar
• Y Ávalos, Canales J, Bravo-Sagua R, et al. Tumor suppression and promotion by autophagy. Biomed Res Int 2014;2014:603980.
   PubMed Web of Science ®Google Scholar
• Castaño-Rodríguez N, Kaakoush NO, Goh KL, et al. Autophagy in Helicobacter pylori infection and related gastric cancer. Helicobacter 2015;20:353–69.
   PubMed Web of Science ®Google Scholar
• Burada F, Plantinga TS, Ioana M, et al. IRGM gene polymorphisms and risk of gastric cancer. J Dig Dis 2012;13:360–5.
   PubMed Web of Science ®Google Scholar
• Du W, Hao X, Yuan Z, et al. Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway. Oncol Lett 2019;18:3195–201.
   PubMed Web of Science ®Google Scholar
• Liu B, Jin J, Zhang Z, et al. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2–AMPK–PGC1α signaling pathway. Biochem Cell Biol 2019;97:397–405.
   PubMed Web of Science ®Google Scholar
• Li B, Yuan Z, Jiang J, et al. Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway. Biosci Rep 2018;38:1–9.
   Web of Science ®Google Scholar
• Liu JP, Liu D, Gu JF, et al. Shikonin inhibits the cell viability, adhesion, invasion and migration of the human gastric cancer cell line MGC-803 via the Toll-like receptor 2/nuclear factor-kappa B pathway. J Pharm Pharmacol 2015;67:1143–55.
   PubMed Web of Science ®Google Scholar
• Papageorgiou VP, Assimopoulou AN, Couladouros EA, et al. The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angew Chem Int Ed 1999;38:270–301.
   PubMed Web of Science ®Google Scholar
• Deng B, Feng Y, Deng B. TIPE2 mediates the suppressive effects of shikonin on MMP13 in osteosarcoma cells. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 2015;37:2434.
   PubMed Web of Science ®Google Scholar
• Andújar I, Ríos JL, Giner RM, et al. Shikonin promotes intestinal wound healing in vitro via induction of TGF-β release in IEC-18 cells. Eur J Pharm Sci 2013;49:637–41.
   PubMed Web of Science ®Google Scholar
• Liu Y, Kang X, Niu G, et al. Shikonin induces apoptosis and prosurvival autophagy in human melanoma A375 cells via ROS-mediated ER stress and p38 pathways, Artif Cells Nanomed Biotechnol 2019;47:626–35.
   Web of Science ®Google Scholar
• Gong K, Zhang Z, Chen Y, et al. Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma. Eur J Pharmacol 2014;738:142–52.
   PubMed Web of Science ®Google Scholar
• Liu T, Xu L, Wang C, et al. Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor-β1/Smads pathway through shikonin. J Gastroenterol Hepatol 2018;34:263.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Hwang KE, Park DS, et al. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells. J Transl Med 2017;15:123.
   PubMed Web of Science ®Google Scholar
• Shi S, Cao H. Shikonin promotes autophagy in BXPC-3 human pancreatic cancer cells through the PI3K/Akt signaling pathway. Oncol Lett 2014;8:1087–9.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li J, Yu Y, et al. Shikonin controls the differentiation of CD4+CD25+ regulatory T cells by inhibiting AKT/mTOR pathway. Inflammation 2019;42:1215–27.
   PubMed Web of Science ®Google Scholar
• Zhang FY, Hu Y, Que ZY, et al. Shikonin inhibits the migration and invasion of human glioblastoma cells by targeting phosphorylated β-catenin and phosphorylated PI3K/Akt: a potential mechanism for the 8Anti-Glioma efficacy of a traditional Chinese herbal medicine. Int J Mol Sci 2015;16:23823–48.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang T, Du J, et al. The critical role of PTEN/PI3K/AKT signaling pathway in shikonin-induced apoptosis and proliferation inhibition of chronic myeloid leukemia. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 2018;47:981–93.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhao G, Zhang D, et al. Active fraction of clove induces apoptosis via PI3K/Akt/mTOR-mediated autophagy in human colorectal cancer HCT-116 cells. Int J Oncol 2018;53:1363–73.
   PubMed Web of Science ®Google Scholar
• Porta C, Paglino C, Mosca A. Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol 2014;4:64.
   PubMedGoogle Scholar
• Xuan Y, Hu X. Naturally-occurring shikonin analogues – a class of necroptotic inducers that circumvent cancer drug resistance. Cancer Lett 2009;274:233–42.
   PubMed Web of Science ®Google Scholar
• Zhen R, Xin L, Wen Z, et al. Synthesis and antitumour activity of β-hydroxyisovalerylshikonin analogues. Eur J Med Chem 2011;46:3934–41.
   PubMed Web of Science ®Google Scholar
• Kong WY, Chen XF, Shi J, et al. Design and synthesis of fluoroacylshikonin as an anticancer agent. Chirality 2013;25:757–62.
   PubMed Web of Science ®Google Scholar
• Lin HY, Li ZK, Bai LF, et al. Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization. Biochem Pharmacol 2015;96:93–106.
   PubMed Web of Science ®Google Scholar
• Kim Y, You YJ, Ahn BZ. Naphthazarin derivatives (VIII): synthesis, inhibitory effect on DNA topoisomerase-I, and antiproliferative activity of 6-(1-acyloxyalkyl)-5,8-dimethoxy-1,4-naphthoquinones. Archiv Der Pharmazie 2001;334:318–22.
   PubMed Web of Science ®Google Scholar
• Sankawa U, Otsuka H, Kataoka Y, et al. Antitumor activity of shikonin, alkannin and their derivatives. II. X-ray analysis of cyclo-alkannin leucoacetate, tautomerism of alkannin and cyclo-alkannin and antitumor activity of alkannin derivatives. Chem Pharm Bull 1981;29:116–22.
   PubMed Web of Science ®Google Scholar
• Wang JQ, Wang X, Wang Y, et al. Novel curcumin analogue hybrids: synthesis and anticancer activity. Eur J Med Chem 2018;156:493–509.
   PubMed Web of Science ®Google Scholar
• Cheng X, Shi JB, Liu H, et al. Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl)methanone through up-regulating hTERT induces cell apoptosis and ER stress. Cell Death Dis 2017;8:e3016.
   PubMed Web of Science ®Google Scholar
• Ke Y, Liang JJ, Hou RJ, et al. Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents. Eur J Med Chem 2018;157:1249–63.
   PubMed Web of Science ®Google Scholar
• Mahdjour S, Guardia JJ, Rodríguez-Serrano F, et al. Synthesis and antiproliferative activity of podocarpane and totarane derivatives. Eur J Med Chem 2018;158:863–73.
   PubMed Web of Science ®Google Scholar
• Shankar R, Chakravarti B, Singh US, et al. Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorg Med Chem 2009;17:3847–56.
   PubMed Web of Science ®Google Scholar
• Senwar KR, Sharma P, Reddy TS, et al. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: design, synthesis, cytotoxicity and apoptosis inducing studies. Eur J Med Chem 2015;102:413–24.
   PubMed Web of Science ®Google Scholar
• Harris MH, Thompson CB. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ 2000;7:1182–91.
   PubMed Web of Science ®Google Scholar
• Gillies LA, Kuwana T. Apoptosis regulation at the mitochondrial outer membrane. J Cell Biochem 2014;115:632–40.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim YC, Fang C, et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 2013;152:290–303.
   PubMed Web of Science ®Google Scholar
• Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000;19:5720–8.
   PubMed Web of Science ®Google Scholar
• Mizushima N. Methods for monitoring autophagy. Int J Biochem Cell Biol 2004;36:2491–502.
   PubMed Web of Science ®Google Scholar
• Chen Y, Azad MB, Gibson SB. Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol 2010;88:285–95.
   PubMed Web of Science ®Google Scholar
• Liu Q LW, Sheng L, Zou C, et al. Design, synthesis and biological evaluation of novel asperphenamate derivatives. Eur J Med Chem 2016;110:76–86.
   PubMed Web of Science ®Google Scholar
• Jiao YN, Wu LN, Xue D, et al. Marsdenia tenacissima extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells. Cancer Cell Int 2018;18:149.
   PubMed Web of Science ®Google Scholar
• Yao D, Zhou Y, Zhu L, et al. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer. Eur J Med Chem 2017;140:155–71.
   PubMed Web of Science ®Google Scholar
• Crighton D WS, Prey JO, Syed N, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006;126:121–34.
   PubMed Web of Science ®Google Scholar
• Shi YH, Ding ZB, Zhou J, et al. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 2011;7:1159–72.
   PubMed Web of Science ®Google Scholar
• Shrivastava A, Kuzontkoski PM, Groopman JE, et al. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Ther 2011;10:1161–72.
   PubMed Web of Science ®Google Scholar
• Wang FY, Xiao-Ming T, Xia W, et al. Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells. Eur J Med Chem 2018;155:639–50.
   PubMed Web of Science ®Google Scholar
• Avan A, Hassanian SM, Ghayour-Mobarhan M, et al. Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer. Curr Med Chem 2017;24:1321–31.
   PubMed Web of Science ®Google Scholar
• Kumar S GS, Pathania AS, Manda S, et al. Fascaplysin induces caspase mediated crosstalk between apoptosis and autophagy through the inhibition of PI3K/AKT/mTOR signaling cascade in human leukemia HL-60 cells. J Cell Biochem 2015;116:985–97.
   PubMed Web of Science ®Google Scholar
• Roy B, Pattanaik AK, Das J, et al. Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells. Chem Biol Interact 2014;210:96–102.
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, et al. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011;8:528–39.
   PubMed Web of Science ®Google Scholar
• Wu YT, Tan HL, Shui G, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 2010;285:10850–61.
   PubMed Web of Science ®Google Scholar